Response Genetics, Inc.
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
You can watch RGDXQ and buy or sell other stocks, ETFs, and their options commission-free!About RGDXQ
Response Genetics, Inc. is engaged in the research and development of clinical diagnostic tests for cancer. Its platforms include analysis of single biomarkers using the polymerase chain reaction method as well as global gene interrogation using microarray methods from paraffin or frozen tissue specimens.
CEOThomas A. Bologna, MBA
CEOThomas A. Bologna, MBA
Employees100
Employees100
HeadquartersLos Angeles, California
HeadquartersLos Angeles, California
Founded1999
Founded1999
Employees100
Employees100
RGDXQ Key Statistics
Market cap3.88K
Market cap3.88K
Price-Earnings ratio—
Price-Earnings ratio—
Dividend yield—
Dividend yield—
Average volume—
Average volume—
High today—
High today—
Low today—
Low today—
Open price—
Open price—
Volume0.00
Volume0.00
52 Week high$0.00
52 Week high$0.00
52 Week low$0.00
52 Week low$0.00
Stock Snapshot
With a market cap of 3.88K, Response Genetics, Inc.(RGDXQ) trades at $0.00.
On 2025-12-16, Response Genetics, Inc.(RGDXQ) stock opened at —, reached a high of —, and a low of —.
The Response Genetics, Inc.(RGDXQ)'s current trading volume is 0.
In the last year, Response Genetics, Inc.(RGDXQ) shares hit a 52-week high of $0.00 and a 52-week low of $0.00.
In the last year, Response Genetics, Inc.(RGDXQ) shares hit a 52-week high of $0.00 and a 52-week low of $0.00.